Macrogenics (MGNX) Non Operating Income (2012 - 2022)
Macrogenics (MGNX) reported Non Operating Income of $819000.0 for Q4 2022, up 282.71% year-over-year from $214000.0 in Q4 2021, and up 476.76% quarter-over-quarter from $142000.0 in Q3 2022.
Macrogenics (MGNX) Non Operating Income (2012 - 2022) Analysis & Trends
Macrogenics (MGNX) has 11 years of Non Operating Income data on file, last reported at $819000.0 in Q4 2022.
- Non Operating Income for Q4 2022 came in at $819000.0, up 282.71% year-over-year; the trailing twelve-month figure through Dec 2022 was $1.7 million (up 144.12% YoY), and the FY2025 annual result was $6.1 million, down 35.71% from the prior year.
- Non Operating Income improved to $819000.0 in Q4 2022 per MGNX's latest filing, from $142000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $21.2 million in Q2 2019 and troughed at -$6.7 million in Q3 2019.
- A 5-year average of $1.4 million and a median of $384500.0 in 2020 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 1881.5% in 2019 and fell as far as 785.85% in 2019.
- A 5-year view of Non Operating Income shows it stood at -$3.0 million in 2018, then jumped by 378.46% to $8.3 million in 2019, then plunged by 99.0% to $83000.0 in 2020, then jumped by 157.83% to $214000.0 in 2021, then jumped by 282.71% to $819000.0 in 2022.
- Business Quant data shows MGNX's Non Operating Income at $819000.0 in Q4 2022, $142000.0 in Q3 2022, and $504000.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 819,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 504,000.00 |
| Mar 31, 2022 | 195,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | 101,000.00 |
| Jun 30, 2021 | 344,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 83,000.00 |
| Sep 30, 2020 | 92,000.00 |
| Jun 30, 2020 | 425,000.00 |
| Mar 31, 2020 | 721,000.00 |
| Dec 31, 2019 | 8.26 Mn |
| Sep 30, 2019 | -6.69 Mn |
| Jun 30, 2019 | 21.20 Mn |
| Mar 31, 2019 | 2.60 Mn |
| Dec 31, 2018 | -2.97 Mn |
| Sep 30, 2018 | 975,000.00 |
| Jun 30, 2018 | 1.07 Mn |
| Mar 31, 2018 | 674,000.00 |